Drugs that are considered standard and investigational therapies for myelodysplastic syndromes (MDS) are listed below, please click on their names for more information:

Generic Name Brand Name
amifostine

Ethyol

anti-thymocyte globulin (ATG, ALG)

Atgam, Thymoglobulin

arsenic trioxide

Trisenox

azacitidine

Vidaza

cyclosporine

Neoral, Sandimmune

darbepoetin alfa

Aranesp

decitabine

Dacogen

epoetin alfa  (Erythropoietin)

Epogen, Procrit

filgrastim (G-CSF)

Neupogen

lenalidomide

Revlimid

mycophenolate mofetil

Cellcept

prednisone

Zarnestra, Tipifarnib

R115777  
sargramostim (GM-CSF)

Leukine

TLK-199

Telintra

thalidomide

Thalomid

VNP40101M

Cloretazine

The information contained on these pages is not comprehensive. It should not be considered medical advice and does not take the place your physician's advice. Although AA&MDSIF strives to provide accurate and up-to-date information, it does not guarantee the accuracy or currency of this information.